These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 10424830)
1. Evaluation of a shared decision making program for women suspected to have a genetic predisposition to breast cancer: preliminary results. Stalmeier PF; Unic IJ; Verhoef LC; Van Daal WA Med Decis Making; 1999; 19(3):230-41. PubMed ID: 10424830 [TBL] [Abstract][Full Text] [Related]
2. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. van Roosmalen MS; Stalmeier PF; Verhoef LC; Hoekstra-Weebers JE; Oosterwijk JC; Hoogerbrugge N; Moog U; van Daal WA J Clin Oncol; 2004 Aug; 22(16):3293-301. PubMed ID: 15310772 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the time-tradeoff values for prophylactic mastectomy of women with a suspected genetic predisposition to breast cancer. Unic I; Stalmeier PF; Verhoef LC; van Daal WA Med Decis Making; 1998; 18(3):268-77. PubMed ID: 9679991 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic mastectomy or screening in women suspected to have the BRCA1/2 mutation: a prospective pilot study of women's treatment choices and medical and decision-analytic recommendations. Unic I; Verhoef LC; Stalmeier PF; van Daal WA Med Decis Making; 2000; 20(3):251-62. PubMed ID: 10929847 [TBL] [Abstract][Full Text] [Related]
5. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771 [TBL] [Abstract][Full Text] [Related]
6. Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results. Sherman KA; Kilby CJ; Shaw LK; Winch C; Kirk J; Tucker K; Elder E Breast; 2017 Dec; 36():79-85. PubMed ID: 29031121 [TBL] [Abstract][Full Text] [Related]
7. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868 [TBL] [Abstract][Full Text] [Related]
9. [Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation]. Vodermaier A; Bauerfeind I; Untch M; Nestle-Krämling C Psychother Psychosom Med Psychol; 2006; 56(9-10):351-61. PubMed ID: 16804803 [TBL] [Abstract][Full Text] [Related]
10. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making. Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640 [TBL] [Abstract][Full Text] [Related]
11. Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret. van Dijk S; van Roosmalen MS; Otten W; Stalmeier PF J Clin Oncol; 2008 May; 26(14):2358-63. PubMed ID: 18467728 [TBL] [Abstract][Full Text] [Related]
12. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429 [TBL] [Abstract][Full Text] [Related]
13. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions. Geller G; Doksum T; Bernhardt BA; Metz SA Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643 [TBL] [Abstract][Full Text] [Related]
14. Predictors of and satisfaction with bilateral prophylactic mastectomy. Stefanek ME; Helzlsouer KJ; Wilcox PM; Houn F Prev Med; 1995 Jul; 24(4):412-9. PubMed ID: 7479633 [TBL] [Abstract][Full Text] [Related]
15. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer. Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247 [TBL] [Abstract][Full Text] [Related]
16. Bilateral prophylactic mastectomy decision making: A vignette study. Stefanek M; Enger C; Benkendorf J; Flamm Honig S; Lerman C Prev Med; 1999 Sep; 29(3):216-21. PubMed ID: 10479610 [TBL] [Abstract][Full Text] [Related]
17. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. Whelan T; Levine M; Willan A; Gafni A; Sanders K; Mirsky D; Chambers S; O'Brien MA; Reid S; Dubois S JAMA; 2004 Jul; 292(4):435-41. PubMed ID: 15280341 [TBL] [Abstract][Full Text] [Related]
18. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Metcalfe KA; Esplen MJ; Goel V; Narod SA Psychooncology; 2004 Jan; 13(1):14-25. PubMed ID: 14745742 [TBL] [Abstract][Full Text] [Related]
19. Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments. Phelps C; Wood F; Bennett P; Brain K; Gray J J Genet Couns; 2007 Aug; 16(4):505-14. PubMed ID: 17318449 [TBL] [Abstract][Full Text] [Related]
20. Patient participation in treatment decision making and the psychological consequences of breast cancer surgery. Moyer A; Salovey P Womens Health; 1998; 4(2):103-16. PubMed ID: 9659000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]